Announcement of the Board of Directors' Approval of Chia Lung's Consolidated Financial Report for the First Quarter of 115 (2026)

1. Date of report to or resolution by the Board of Directors: 2026/05/08 2. Date of approval by the Audit Committee: 2026/05/08 3. Reporting period for financial report or annual self-reported financial information: 2026/01/01~2026/03/31 4. Cumulative operating revenue from January 1 to the end of this period (in thousands NTD): 445,902 5. Cumulative operating gross profit (loss) from January 1 to the end of this period (in thousands NTD): 60,667 6. Cumulative operating income (loss) from January 1 to the end of this period (in thousands NTD): 26,231 7. Cumulative profit (loss) before tax from January 1 to the end of this period (in thousands NTD): 5,034 8. Cumulative net profit (loss) for this period from January 1 to the end of this period (in thousands NTD): 5,034 9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands NTD): 5,034 10. Cumulative basic earnings per share (loss) from January 1 to the end of this period (NTD): 0.05 11. Total assets at the end of the period (in thousands NTD): 3,058,511 12. Total liabilities at the end of the period (in thousands NTD): 1,813,425 13. Equity attributable to owners of the parent company at the end of the period (in thousands NTD): 1,245,086 14. Other matters that should be specified: None